Figure 3.
Meta‐analysis on comparative trials comparing the addition of plasma exchange (PLEX) for induction therapy in patients with glomerulonephritis: mortality: risk ratio (A); end stage kidney disease: hazard ratio in random effects model (top panel) and fixed‐effects model (bottom panel) (B); end stage kidney disease: risk ratio (C); remission: risk ratio (D); serious adverse events: risk ratio (E); serious adverse events: rate ratio (F); and severe infections: rate ratio (top panel) and relative risk (bottom panel) (G).